COVID-19 vaccines vs variants — Determining how much immunity is enough | FDA for emergency use authorization |
---|---|
Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States | Centers for Disease Control and Prevention |
---|---|
Frequently asked questions about COVID-19 vaccination | COVID-19 vaccines and allergic reactions |
Centers for Disease Control and Prevention | |
---|---|
Centers for Disease Control and Prevention | FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine |
Vaccination considerations for persons with underlying medication conditions.
18